In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair

The clinical use of human bone marrow–derived mesenchymal stem cells (BM-MSCs) has been hampered by their poor performance after transplantation into failing hearts. Here, to improve the therapeutic potential of BM-MSCs, we developed a strategy termed in vivo priming in which BM-MSCs are primed in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Bong-Woo, Jung, Soo-Hyun, Das, Sanskrita, Lee, Soon Min, Park, Jae-Hyun, Kim, Hyeok, Hwang, Ji-Won, Lee, Sunghun, Kim, Hyo-Jin, Kim, Hey-Yon, Jung, Seungman, Cho, Dong-Woo, Jang, Jinah, Ban, Kiwon, Park, Hun-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141892/
https://www.ncbi.nlm.nih.gov/pubmed/32284967
http://dx.doi.org/10.1126/sciadv.aay6994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141892/
https://www.ncbi.nlm.nih.gov/pubmed/32284967
http://dx.doi.org/10.1126/sciadv.aay6994

Ejemplares similares